Dyskerin pseudouridine synthase 1 (DKC1)

Dyskerin pseudouridine synthase 1 (DKC1) is an ancient, highly conserved enzyme that catalyzes the post-transcriptional modification of uridine residues to pseudouridine in RNAs. This modification increases RNA stability and regulates ribosome biogenesis and splicing events. Dyskerin forms the core of the H/ACA ribonucleoprotein complex, associating with specific guide RNAs and proteins (NAP57, NHP2, NOP10, GAR1) to direct site-specific pseudouridylation of rRNA, snRNA, and mRNA substrates. In addition to its role in RNA modification, dyskerin is essential for telomerase holoenzyme function, stabilizing the telomerase RNA component (TERC) and supporting telomere maintenance, which is critical for chromosome integrity and cellular aging. Mutations in the DKC1 gene result in syndromes including X-linked dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome, characterized by bone marrow failure, telomere shortening, premature aging, and increased cancer risk. There are currently no approved drugs targeting dyskerin directly, but its importance in disease pathways and fundamental cellular processes makes it a key molecule of interest for therapeutic and diagnostic applications.

Other names

H/ACA ribonucleoprotein complex subunit DKC1DyskerinNOLA4NAP57Cbf5 (homolog)XAP101Nucleolar protein family A member 4snoRNP protein DKC1Dyskeratosis congenita 1Nopp140-associated protein of 57 kDa

Hypothetical mechanisms include inhibition of pseudouridylation, telomerase complex modulation, and RNA-protein interaction interference. Experimental approaches may involve RNA editing or targeting substrate interactions, but no specific drug mechanisms have been clinically established.